Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
European Journal of Pain (London, England)|September 26, 2024
Geographical disparities in fibromyalgia severity: An Italian studyMarco Di Carlo, Sonia Farah, Fabiola Atzeni, et al.
Clinical and Experimental Rheumatology|January 10, 2024
Effectiveness and safety of filgotinib in rheumatoid arthritis: a real-life multicentre experienceLidia La Barbera, Chiara Rizzo, Federica Camarda, et al.
Rheumatology International|June 5, 2026
Clinical associations and related factors of metabolic syndrome in systemic sclerosis: results from an observational multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)Vasiliki Liakouli, Giulio Forte, Piero Ruscitti, et al.
Rheumatology (Oxford, England)|August 4, 2025
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinibGiuseppe Lopalco, Eleonora Celletti, Maria Morrone, et al.
Rheumatology (Oxford, England)|May 25, 2026
Early belimumab accelerates renal response and reduces glucocorticoid exposure in lupus nephritis: a multicenter propensity-matched studyMariele Gatto, Claudio Cruciani, Marta Calatroni, et al.
Clinical and Experimental Rheumatology|August 17, 2024
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)Vasiliki Liakouli, Ignazio Verde, Piero Ruscitti, et al.
Rheumatology Advances in Practice|March 22, 2024
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaireElena Treppo, Miriam Isola, Maria De Martino, et al.
Biologics : Targets & Therapy|November 5, 2025
Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0)Marisol Bracalenti, Margherita Zen, Benedetta Bianchi, et al.
RMD Open|June 16, 2023
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD groupFrancesco Ursini, Piero Ruscitti, Olga Addimanda, et al.
Rheumatology (Oxford, England)|April 26, 2025
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre studyPaolo Delvino, Luca Quartuccio, Joanna C Robson, et al.
Pageof 8